The CARDIOPROTECT Trial

NCT07654426 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-cell Lymphoma (DLBCL)
Cardiotoxicity
Lymphoma

Interventions

DRUG: Dexrazoxane
DRUG: Dexrazoxane placebo
DRUG: Doxorubicin
DRUG: Liposomal Doxorubicin
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Prednisone
DRUG: Rituximab
DRUG: Polatuzumab Vedotin

Sponsor

Beth Israel Deaconess Medical Center